Avaí Bio Statistics
Total Valuation
Avaí Bio has a market cap or net worth of 52.76 million. The enterprise value is 54.01 million.
| Market Cap | 52.76M |
| Enterprise Value | 54.01M |
Important Dates
The last earnings date was Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Avaí Bio has 138.03 million shares outstanding. The number of shares has increased by 24.77% in one year.
| Current Share Class | 138.03M |
| Shares Outstanding | 138.03M |
| Shares Change (YoY) | +24.77% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 18.78% |
| Owned by Institutions (%) | n/a |
| Float | 27.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -22.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -58.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -282.14% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 40.46% |
| Weighted Average Cost of Capital (WACC) | 8.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.01% in the last 52 weeks. The beta is 0.86, so Avaí Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -37.01% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 36.61 |
| Average Volume (20 Days) | 132,534 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.25 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -930,831 |
| Pretax Income | -930,831 |
| Net Income | -930,831 |
| EBITDA | -882,511 |
| EBIT | -930,831 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 91,995 in cash and 1.32 million in debt, with a net cash position of -1.23 million or -0.01 per share.
| Cash & Cash Equivalents | 91,995 |
| Total Debt | 1.32M |
| Net Cash | -1.23M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -2.30M |
| Book Value Per Share | -0.02 |
| Working Capital | -2.42M |
Cash Flow
| Operating Cash Flow | -933,743 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Avaí Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.77% |
| Shareholder Yield | -24.77% |
| Earnings Yield | -1.76% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2020. It was a forward split with a ratio of 20.
| Last Split Date | Jun 1, 2020 |
| Split Type | Forward |
| Split Ratio | 20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |